Effects of oral chondroitin sulfate on the progression of knee osteoarthritis: A pilot study

Osteoarthritis and Cartilage

Volumn 6, Issue SUPPL. A, 1998, Pages 39-46

  Uebelhart, D ^a   Thonar, E J M A ^a   Delmas, P D ^a   Chantraine, A ^a   Vignon, E ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

Biochemical markers; Chondrometry; Osteoarthritis; SYSADOA

Indexed keywords

BIOCHEMICAL MARKER; CHONDROITIN SULFATE;

ADULT; AGED; BONE METABOLISM; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG TOLERABILITY; FEMALE; HUMAN; IMAGE ANALYSIS; KNEE OSTEOARTHRITIS; MAJOR CLINICAL STUDY; MALE; ORAL DRUG ADMINISTRATION; PILOT STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 0031747132     PISSN: 10634584     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1063-4584(98)80011-3     Document Type: Conference Paper

References (35)

1. Altman R Asch E Bloch D Bole G Borenstein D Brandt K Development of criteria for the classification and reporting of osteoarthritis: classification of osteoarthritis of the knee Arthritis Rheum 29 1986 1039 1049
2. Lequesne M Symptomatic slow-acting drugs in ostoarthritis: a novel therapeutic concept? Rev Rhum (Engl. Ed.) 61 1994 69 73
3. Lequesne M Brandt K Bellamy N Moskowitz R Menkès CJ Pelletier JP Guidelines for testing slow acting drugs in osteoarthritis J Rheumatol 21 1994 65 73
4. Bradley JD Brandt KD Katz BP Kalasinski LA Ryan SI Treatment of knee osteoarthritis: relationship of clinical features of joint inflammation to the response to a nonsteroidal anti inflammatory drug or pure analgesic J Rheumatol 19 1992 1950 1954
5. March L Irwig L Schwarz J Simpson J Chock C Brooks P n Of 1 trials comparing a non-steroidal anti-inflammatory drug with paracetamol in osteoarthritis BMJ 309 1994 1041 1045
6. Dieppe PA Frankel SJ Toth B Is research into the treatment of osteoarthritis with non steroidal anti-inflammatory drugs misdirected? Lancet 341 1993 353 354
7. Langman MJS Weil J Wainwright P Lawson DH Rawlins MD Logan RF Risks of bleeding peptic ulcer associated with individual non-steroidal anti-inflammatory drugs Lancet 343 1994 1075 1078
8. Agrawal NM Epidemiology and prevention of non-steroidal anti-inflammatory drug effects in the gastro-intestinal tract Br J Rheumatol 34 1995 5 10
9. Delmas PD Non-steroidal anti-inflammatory drugs and renal function Br J Rheumatol 34 1995 25 28
10. Gosh P Nonsteroidal anti-inflammatory drugs and chondroprotection. A review of the evidence Drugs 46 1993 834 846
11. Howell DS Altman RD Cartilage repair and conservation in osteoarthritis Rheum Dis Clin N Am 19 1993 713 724
12. Conte A De Bernardi M Palmieri L Lualdi P Mautone G Ronca G Metabolic fate of exogenous chondroitin sulfate in man Arzeim-Forsch/Drug Res 41 1991 768 772
13. Palmieri L Conte A Giovannini L Lualdi P Ronca G Metabolic fate of exogenous chondroitin sulfate in the experimental animal Arzeim-Forsch/Drug Res 40 1990 319 323
14. Baici A Hörler D Moser B Hofer HO Fehr K Wagenhäuser FJ Analysis of glycosaminoglycans in human serum after oral administration of chondroitin sulfate Rheumatol Int 12 1992 81 88
15. Mazières B Loyau G Menkès CJ Valat JP Dreiser RL Charlot J Le chondroitine sulfate dans le traitement de la gonarthrose et de la coxarthrose Rev Rhum 59 1992 466 472
16. Morreale P Manopulo R Galati M Boccanera L Saponati G Bocchi L Comparison of the anti inflammatory efficacy of chondroitin sulfate and diclofenac sodium in patients with knee osteoarthritis J Rheumatol 23 1996 1385 1391
17. Huskisson EC Assessment for clinical trials Clin Rheum Dis 2 1 1976 37 49
18. Conrozier T Tron AM Mathieu P Vignon E Quantitative assessment of radiographic normal and osteoarthritic hip joint space Osteoarth Cart 3 1995 81 87
19. Garnero P Grimaud M Demiaux B Preaudat C Seguin P Delmas PD Measurement of serum osteocalcin with a human-specific two-site immunoradio matric assay J Bone Min Res 7 1992 1389 1398
20. Thonar EJMA Lenz ME Klintworth GK Caterson B Pachman L Glickman P Quantification of keratan sulfate in blood as a marker of cartilage catabolism Arthritis Rheum 28 1984 1367 1376
21. Uebelhart D Gineyts E Chapuy MC Delmas PD Urinary excretion of pyridinium crosslinks: a new marker of bone resorption in metabolic bone disease Bone and Mineral 8 1990 87 96
22. Moskowitz RW Chondroprotective agents. Do they already exist? Europ J Rheum Inflam 11 1991 21 25
23. Wight TN Heinegard DK Hascall VC Proteoglycans, structure and function Hay ED Cell Biology of Extracellular Matrix 2nd ed. 1991 Plenum Press New York 45 78
24. Hascall VC Heinegard DK Wight TN Proteoglycans, metabolism and pathology Hay ED Cell Biology of Extracellular Matrix 2nd ed. 1991 Plenum Press New York 149 175
25. Hardingham T Bayliss M Proteoglycans of articular cartilage: changes in aging and in joint disease Sem Arthritis Rheum 20 1990 12 33
26. Gosh P Wells C Smith M Hutadilok N Chondro-protection, myth or reality: an experimental approach Sem Arthritis Rheum 19 1990 3 9
27. Liau YH Galicki N Horowitz MI Degradation of chondroitin 4-sulfate by rat stomach exoglycosidases, sulfhydrolase and hyaluronidase-like enzymes Digestion 21 1981 117 124
28. Vignon E Clinical trials of oral chondroitin sulfatein the treatment of osteoarthritis Rainsford KD Advances in anti-rheumatic therapy 1995 CRC Press Boca Raton
29. Buckland-Wright JC Quantitative radiography of osteoarthritis Ann Rheum Dis 53 1994 268 275
30. Buckland-Wright JC Macfarlane DG Lynch JA Jasani MK Bradshaw CR Joint space width measures cartilage thickness in osteoarthritis of the knee: high resolution plain film and double contrast macroradiographic investigation Ann Rheum Dis 54 1995 263 268
31. Dougados M Viller C Amor B Sensitivity to change of various roentgenological severity scoring systems for osteoarthritis of the hip Rev Rhum (Engl. Ed.) 62 1995 169 173
32. Lequesne M Chondrometry. Quantitative evaluation of joint space width and rate of joint space loss in osteoarthritis of the hip Rev Rhum (Engl. Ed.) 62 1995 155 158
33. Thonar EJMA Shinmei M Lohmander LS Body fluid markers of cartilage changes in osteoarthritis Rheum Dis Clin N Am 19 1993 635 657
34. Thonar EJ-MA Manicourt DM Williams JM Fukuda K Campion GV Sweet MBE Serum keratan sulfate: a measure of cartilage proteoglycan metabolism Kuettner KE Schleyerbach R Peyron JG Hascall VC Articular Cartilage and Osteoarthritis 1992 Raven Press New York 429 445
35. Thonar EJ-MA Shinmei M Lohmander LS Body fluid markers of cartilage changes in osteoarthritis Moskowitz RW Rheumatic Disease Clinics of North America: Osteoarthritis 1993 W.B. Saunders Philadelphia 635 657